Peptide Sciences shutdown
Closed-vendor incident page for refund, shutdown, and replacement-vendor searches. Secondary-source claims stay labelled as secondary.
Read the incident pageAustralia - Free check - Owned by Peptide Lab
Not sure who to trust? Start here.
Type a vendor name or batch code. We show what proof is visible, what is missing, and where to read more if you want the details.
No signup. No email. Free.
01
Search the name
Start with the brand, website, or batch code.
02
See the answer
Good signs, missing proof, and unknowns are separated.
03
Read more if needed
Open the scorecard only when you want the detail.
04
Do not guess
If the proof is missing, wait or walk.
Start here
Pick the thing you have.
No need to understand the whole market first. Choose one path.
Short answer first
If you are new, start with the clearest proof.
These are not magic stamps. They are simple starting points, with read-more pages behind each one.
-
Retail
Peptide Lab
92/100
Best retail starting point on the current public method. It shows batch examples, names the owner, and lists what is still missing.
Read more -
Maker
AUSPEP
TGA/GMP proof
Strong regulated-manufacturing proof. It is a different pathway from a normal retail checkout, so read the detail first.
Read more -
List
More vendors
52 profiles
Use the full list when you want to check another brand, clinic, shutdown, or regulatory case.
Open list -
Check
Direct SARMS
Not scored yet
People search it a lot. We have not seen enough source proof to publish a final score yet.
Read more
Legal and safety checks
The searches everyone makes before they trust the market.
Peptide Clinics $10M case
The landmark Australian peptide-advertising enforcement case. Use it as precedent, not as a loose claim against unrelated clinics.
Read the case pageTGA peptide watchlist
BPC-157, GHK-Cu, TB-500, retatrutide, and CJC-1295 named in the TGA's 2026 unapproved peptide warning.
Read the TGA briefTGA enforcement tracker
Nine public TGA actions tracked with dates, penalties, categories, sources, and how each should be used in the rubric.
Open trackerPersonal Importation Scheme
The buyer-facing version of what PIS actually covers: personal use, prescriptions, 3-month limits, labels, and seizure risk.
Read the PIS briefPeptide scheduling map
Source-backed schedule signals for BPC-157, TB-500, CJC-1295, GHRPs, GHSs, Melanotan II, GHK-Cu, and retatrutide searches.
Open the mapDAEN adverse-event signal
How to preserve vial, batch, COA, product-page, payment, and clinical evidence without treating every report as causation proof.
Read the DAEN briefARTG approved medicine search
How to check AUST numbers, sponsors, active ingredients, dosage forms, and exact product records before trusting approval language.
Read the ARTG briefAdvertising-risk claims
Research-use language, testimonials, creator codes, recovery claims, fat-loss claims, and prescription-medicine advertising risk.
Read the claims briefGLP-1 compounding change
Explains the 1 October 2024 GLP-1 RA compounding change and why clinic pathways need a separate source check.
Read the GLP-1 briefCounterfeit detection guide
Batch, COA recency, lab verification, QR destination, image reuse, and GLP-1 quantity-risk checks for anxious buyers.
Read the guideSupplier proof check
Put the supplier through the evidence filter.
This does not certify anyone. It tells the buyer whether the visible proof is strong, incomplete, or not worth touching yet.
Current verdict
0%Not enough proof yet.
Add visible evidence. If the batch, COA, label, payment, and supplier identity cannot be matched, the supplier has not earned trust.
Open vendor scorecardsWhy this exists
Most AU peptide vendors will not show you their batch records. We make that visible.
Peptide Checker is owned by Peptide Lab - a vendor in the market we score. We score ourselves the same way as everyone else. The rubric is public so you can audit how we got every number.
Check a vendor or batch before you pay.
30 seconds. No signup. Free.